1 / 5

Heart failure and comorbidities

Heart failure and comorbidities. Analysis of the European Heart Failure Pilot Survey. van Deursen VM et al. Co-morbidities in patients with heart failure : an analysis of the European Heart Failure Pilot Survey. Europ J Heart Fail . 2014;16:103-111.

lorenzo-romero
Download Presentation

Heart failure and comorbidities

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Heart failure and comorbidities Analysis of the EuropeanHeartFailure Pilot Survey van Deursen VM et al. Co-morbidities in patients withheartfailure: an analysis of the EuropeanHeartFailure Pilot Survey. Europ J Heart Fail. 2014;16:103-111.

  2. Zoom on patients with comorbidities in Europe Comorbidities frequentlyaccompanyheartfailure, leading to increasedmorbidity and mortality, and decreasedquality of life. 3226 outpatientswith chronicheartfailure analysed AIM OF THE ANALYSIS Assessing the - prevalence, - prognostic implications, - determinents, and - regional variation, of their comorbidities. van Deursen VM et al. Co-morbidities in patients withheartfailure: an analysis of the EuropeanHeartFailure Pilot Survey. Europ J Heart Fail. 2014;16:103-111.

  3. Prevalence of comorbidities in heart failure …the mostprevalentbeing… 41% 74% 29% 29% Proportion of HF patients suffering fromat least 1comorbidity 15% 11% The number of comorbidities increases with the severity of heart failure. van Deursen VM et al. Co-morbidities in patients withheartfailure: an analysis of the EuropeanHeartFailure Pilot Survey. Europ J Heart Fail. 2014;16:103-111.

  4. Prognostic implications of comorbidities in heart failure Prognostic implications of comorbidities are assessed by population attributable risks (PARs*), corresponding to the % of all-cause mortality in the population attributable to the comorbidity: Chronic Kidney Disease Anemia Diabetes COPD 41% (95% CI, 29-51%) 37% (95% CI, 27-46%) 14% (95% CI, 5-–23%) 10% (95% CI, 3-16%) * “PAR can be described as the reduction in mortality that would be observed if the population was entirely unexposed to a certain c-morbidity, compared with the mortality pattern in patients without that comorbidity” van Deursen VM et al. Co-morbidities in patients withheartfailure: an analysis of the EuropeanHeartFailure Pilot Survey. Europ J Heart Fail. 2014;16:103-111.

  5. Determinents and regional variations of comorbidities in heart failure • Patients with comorbidities: • - older • - more advanced heart failure (reflected by a higher NYHA class) • - higher prevalence of hypertension and AF • although a causal relationship cannot be established based on the data. • - more comorbidities  more clinical signs of congestion (elevated JVP or peripheral oedema) • - less likely to be receiving evidence-based therapies, such as ACEis, ARBs, and β-blockers. • Patients with heart failure of ischemic aetiology had more comorbidities. • Across various European regions, there are marked differences in prevalence and prognostic implications of comorbidities. Patients with increasing numbers of comorbidities have an increasing risk of both mortality and heart failure hospitalization. van Deursen VM et al. Co-morbidities in patients withheartfailure: an analysis of the EuropeanHeartFailure Pilot Survey. Europ J Heart Fail. 2014;16:103-111.

More Related